Wednesday, November 29, 2006

New Study Gives Hope for Fibromyalgia Sufferers

A new study just released by NuScience Corporation shows a significant decrease in some of the symptoms related to Fibromyalgia. The study done by Professor Roberto Marcolongo at the University of Siena, Italy, looked at the efficacy of treating patients diagnosed with Fibromyalgia with a specific blend of 129 nutrients called CELLFOOD.
Las Vegas, NV (PRWEB) November 29, 2006 -- A new study just released by NuScience Corporation shows a significant decrease in some of the symptoms related to Fibromyalgia. The study done by Professor Roberto Marcolongo at the University of Siena, Italy, looked at the efficacy of treating patients diagnosed with Fibromyalgia with a specific blend of 129 nutrients called CELLFOOD.In the study, CELLFOOD effectively reduced pain associated with Fibromyalgia by more than 31% over a 90-day period. CELLFOOD was also shown to decrease specific tender point pain by up to 40% during that same period. "Needless to say, the results were dramatic and very encouraging. Based on the results of this preliminary study, a third study has been initiated increasing the dosage of CELLFOOD as well as the length of the treatment period" said David McKinney, Vice President of NuScience Corporation, the makers of CELLFOOD. "CELLFOOD is a nutritional supplement in a colloidal solution based on oxygen, trace minerals, amino acids and enzymes. It emanates H+ ions (used for metabolic normalization of the acidosis) and O- ions that react with oxygen free radicals, and leads to the forming of molecular bio-available oxygen. CELLFOOD, which causes the elimination of oxygen free radicals, produces rising oxygen and provides optimal cellular nutrition." According to the study, "this new therapeutic approach could effectively provide an important contribution in the treatment of patients afflicted with Fibromyalgia syndrome; both from chronic pain and from chronic fatigue symptoms associated with FMS, therefore reducing the need to explore more complex pharmacological solutions."This is good news for the hundreds of thousands of people diagnosed with Fibromyalgia, suffering from painful symptoms. Fibromyalgia (FM) is an increasingly recognized chronic pain illness characterized by widespread musculoskeletal aches, pain and stiffness, soft tissue tenderness, general fatigue and sleep disturbances. The most common sites of pain include the neck, back, shoulders, pelvic girdle and hands, but any body part can be involved. Fibromyalgia patients experience a range of symptoms of varying intensities that wax and wane over time.OxyWave LLC has been an online provider of Cellfood nutritional products since early 1998. A free copy of the Fibromyalgia study can be downloaded at: http://www.oxywave.com/.
http://www.prweb.com/releases/2006/11/prweb484627.htm

No comments: